CDK19 and breast carcinoma: Analysis of the transcriptome data of 968 breast cancer patients has uncovered increased levels of CDK8/CDK19 paralleled by enhanced levels of cyclin C and MED13 compared to samples from patients with benign or hyperplastic breast cancers and from normal mammary tissues [44].